Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.

Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE Jr, Williams JV, Melendi GA, Polack FP.

Nat Med. 2011 Feb;17(2):195-9. doi: 10.1038/nm.2262. Epub 2010 Dec 5.

2.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

3.

Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis.

Gao R, Bhatnagar J, Blau DM, Greer P, Rollin DC, Denison AM, Deleon-Carnes M, Shieh WJ, Sambhara S, Tumpey TM, Patel M, Liu L, Paddock C, Drew C, Shu Y, Katz JM, Zaki SR.

Am J Pathol. 2013 Oct;183(4):1258-68. doi: 10.1016/j.ajpath.2013.06.023. Epub 2013 Aug 11.

PMID:
23938324
4.

High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

To KK, Zhang AJ, Hung IF, Xu T, Ip WC, Wong RT, Ng JC, Chan JF, Chan KH, Yuen KY.

Clin Vaccine Immunol. 2012 Jul;19(7):1012-8. doi: 10.1128/CVI.00081-12. Epub 2012 May 9.

5.

Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.

Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.

Int J Infect Dis. 2012 Aug;16(8):e621-7. doi: 10.1016/j.ijid.2012.04.010. Epub 2012 Jun 15.

6.

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, Gentleman B, Purych D, Gardy J, Patrick DM, Brunham RC, De Serres G, Petric M.

J Infect Dis. 2011 Jan 15;203(2):158-67. doi: 10.1093/infdis/jiq039.

7.

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE.

PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.

8.

Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.

Makkoch J, Payungporn S, Prachayangprecha S, Tantilertcharoen R, Poovorawan Y.

Asian Pac J Allergy Immunol. 2010 Mar;28(1):67-75.

9.

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.

N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.

10.

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.

O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S.

PLoS One. 2011 Mar 9;6(3):e17377. doi: 10.1371/journal.pone.0017377.

11.

Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection.

Nakajima N, Sato Y, Katano H, Hasegawa H, Kumasaka T, Hata S, Tanaka S, Amano T, Kasai T, Chong JM, Iizuka T, Nakazato I, Hino Y, Hamamatsu A, Horiguchi H, Tanaka T, Hasegawa A, Kanaya Y, Oku R, Oya T, Sata T.

Mod Pathol. 2012 Jan;25(1):1-13. doi: 10.1038/modpathol.2011.125. Epub 2011 Aug 26. Erratum in: Mod Pathol. 2012 Mar;25(3):492. Iiduka, Toshihiko [corrected to Iizuka, Toshihiko]; Hasagawa, Akio [corrected to Hasegawa, Akio].

12.

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, Fluckiger AC, Klatzmann D, Carrat F.

Clin Microbiol Infect. 2011 May;17(5):732-7. doi: 10.1111/j.1469-0691.2010.03352.x. Epub 2010 Oct 29.

13.

Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.

Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, Tsukamoto Y.

Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.

PMID:
21468553
14.

Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6.

Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, Shao J, Shen J, Gao Y, Yuan Z, Wu F.

PLoS One. 2011;6(12):e28680. doi: 10.1371/journal.pone.0028680. Epub 2011 Dec 9.

15.

Humoral and cell-mediated immunity to pandemic H1N1 influenza in a Canadian cohort one year post-pandemic: implications for vaccination.

Wagar LE, Rosella L, Crowcroft N, Lowcock B, Drohomyrecky PC, Foisy J, Gubbay J, Rebbapragada A, Winter AL, Achonu C, Ward BJ, Watts TH.

PLoS One. 2011;6(11):e28063. doi: 10.1371/journal.pone.0028063. Epub 2011 Nov 23.

16.

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.

Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.

Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.

17.

Serologic status for pandemic (H1N1) 2009 virus, Taiwan.

Huang DT, Shao PL, Huang KC, Lu CY, Wang JR, Shih SR, Chi H, Lai MR, Lee CY, Chang LY, Huang LM.

Emerg Infect Dis. 2011 Jan;17(1):76-8. doi: 10.3201/eid1701.100014.

18.

Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.

Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W.

J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895.

PMID:
20872705
19.

[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].

You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Chinese.

PMID:
22338222
20.

Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.

Booy R, Khandaker G, Heron LG, Yin J, Doyle B, Tudo KK, Hueston L, Gilbert GL, Macintyre CR, Dwyer DE.

Med J Aust. 2011 Jan 3;194(1):19-23.

PMID:
21449863
Items per page

Supplemental Content

Write to the Help Desk